The combined therapy could downregulate MCL-1 levels by suppressing the phosphorylation of STAT3; therefore, we sought to determine whether altering the expression of STAT3 in NPC cells would affect tumor cell apoptosis induced by APG-1252-M1 plus gemcitabine. The gene discussed is MCL1; the disease is neoplasm.